A detailed history of Zacks Investment Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Zacks Investment Management holds 255,818 shares of BSX stock, worth $26 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
255,818
Previous 237,927 7.52%
Holding current value
$26 Million
Previous $18.3 Million 17.0%
% of portfolio
0.19%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $1.31 Million - $1.5 Million
17,891 Added 7.52%
255,818 $21.4 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $5.34 Million - $6.16 Million
79,252 Added 49.95%
237,927 $18.3 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $9.14 Million - $10.9 Million
158,675 New
158,675 $10.9 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $132,456 - $234,400
-5,128 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $194,197 - $232,657
5,128 New
5,128 $232,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.